Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables RefundsShares OutstandingShort-Term Debt repayments
Ratios

Cue Biopharma (CUE) Long-Term Debt Issuances (2022)

Historic Long-Term Debt Issuances for Cue Biopharma (CUE) over the last 1 years, with Q1 2022 value amounting to $10.0 million.

  • Cue Biopharma's Long-Term Debt Issuances changed N/A to $10.0 million in Q1 2022 from the same period last year, while for Dec 2022 it was $10.0 million, marking a year-over-year change of. This contributed to the annual value of $18000.0 for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q1 2022, Cue Biopharma's Long-Term Debt Issuances is $10.0 million.
  • Cue Biopharma's 5-year Long-Term Debt Issuances high stood at $10.0 million for Q1 2022, and its period low was $10.0 million during Q1 2022.